373 related articles for article (PubMed ID: 20950166)
21. Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.
Blumsohn A; Marin F; Nickelsen T; Brixen K; Sigurdsson G; González de la Vera J; Boonen S; Liu-Léage S; Barker C; Eastell R;
Osteoporos Int; 2011 Jun; 22(6):1935-46. PubMed ID: 20938767
[TBL] [Abstract][Full Text] [Related]
22. Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk.
Nakamura T; Sugimoto T; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Yoshikawa H; Nishizawa Y; Fujita T; Shiraki M
J Clin Endocrinol Metab; 2012 Sep; 97(9):3097-106. PubMed ID: 22723322
[TBL] [Abstract][Full Text] [Related]
23. Study investigates novel approach to bone loss in the jaw.
Garg A; Guez G
Dent Implantol Update; 2011 Feb; 22(2):9-15. PubMed ID: 21425753
[No Abstract] [Full Text] [Related]
24. Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.
Yamamoto T; Tsujimoto M; Sowa H
Clin Interv Aging; 2015; 10():1101-9. PubMed ID: 26185429
[TBL] [Abstract][Full Text] [Related]
25. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw.
Ohbayashi Y; Miyake M; Sawai F; Minami Y; Iwasaki A; Matsui Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):e31-7. PubMed ID: 23246226
[TBL] [Abstract][Full Text] [Related]
26. Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study.
Miyauchi A; Matsumoto T; Shigeta H; Tsujimoto M; Thiebaud D; Nakamura T
J Bone Miner Metab; 2008; 26(6):624-34. PubMed ID: 18979163
[TBL] [Abstract][Full Text] [Related]
27. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
28. Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks.
Aspenberg P; Malouf J; Tarantino U; García-Hernández PA; Corradini C; Overgaard S; Stepan JJ; Borris L; Lespessailles E; Frihagen F; Papavasiliou K; Petto H; Caeiro JR; Marin F
J Bone Joint Surg Am; 2016 Nov; 98(22):1868-1878. PubMed ID: 27852903
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
[TBL] [Abstract][Full Text] [Related]
30. Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient.
Neuprez A; Rompen E; Crielaard JM; Reginster JY
Calcif Tissue Int; 2014 Jul; 95(1):94-6. PubMed ID: 24804929
[TBL] [Abstract][Full Text] [Related]
31. Use of teriparatide in osteoporotic fracture patients.
Collinge C; Favela J
Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
33. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.
Saag KG; Zanchetta JR; Devogelaer JP; Adler RA; Eastell R; See K; Krege JH; Krohn K; Warner MR
Arthritis Rheum; 2009 Nov; 60(11):3346-55. PubMed ID: 19877063
[TBL] [Abstract][Full Text] [Related]
34. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
[TBL] [Abstract][Full Text] [Related]
35. Teriparatide increases the maturation of circulating osteoblast precursors.
D'Amelio P; Tamone C; Sassi F; D'Amico L; Roato I; Patanè S; Ravazzoli M; Veneziano L; Ferracini R; Pescarmona GP; Isaia GC
Osteoporos Int; 2012 Apr; 23(4):1245-53. PubMed ID: 21617993
[TBL] [Abstract][Full Text] [Related]
36. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
[TBL] [Abstract][Full Text] [Related]
37. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
Nakatoh S
J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
Ettinger B; San Martin J; Crans G; Pavo I
J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
[TBL] [Abstract][Full Text] [Related]
39. Treatment of adult hypophosphatasia with teriparatide.
Camacho PM; Painter S; Kadanoff R
Endocr Pract; 2008 Mar; 14(2):204-8. PubMed ID: 18308659
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Osteonecrosis of the Jaw.
Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
